Subscribe To
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Sangamo therapeutics to present pre-clinical data showcasing its epigenetic regulation for neurology and car-treg research at the 30th annual congress of the european society of gene & cell therapy (e
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epi...
October 24, 2023, 2:01 am
Alphabet earnings are coming. expect strength in ads and cloud computing.
The Street expects the parent of Google and YouTube to post sales of $76 billion, up 10% from a year earlier, with prof...
October 24, 2023, 2:00 am
Btc/usd: is bitcoin back?
Bitcoin hits $31,000, highest levels since July Michael Saylor’s MicroStrategy Bitcoin position turns...
October 24, 2023, 1:45 am
First meeting of china - us economic working group, candid and constructive discussions
China finance ministry readout: Two sides had in-depth, candid and constructive discussions on the macroeconomic situation and policies of the two cou...
October 24, 2023, 1:37 am
Novo nordisk: growing to potentially become the first trillion-dollar european champion
Novo Nordisk stock has tripled since 2020 and is up over 30% YTD; but there is still upside. Novo is poised to benefit from the surging demand for dia...
October 24, 2023, 1:24 am
Delta air lines is still head and shoulders above the rest
Delta Air Lines stock has outperformed its competitors in the U.S. airline industry, holding onto gains...
October 24, 2023, 1:16 am
Pboc sets usd/ cny central rate at 7.1786 (vs. estimate at 7.2992)
The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. ...
October 24, 2023, 1:15 am
Novartis lifts 2023 earnings forecast for third time
Novartis on Tuesday raised its full-year earnings forecast for the third time on strong drug sales, aft...
October 24, 2023, 1:12 am
Mizuho financial group offers value for your money
Mizuho Financial has made headway in lifting meager returns characteristic of Japanese banks. The company has set a good foundation for integrated cro...
October 24, 2023, 1:10 am
Wabash national corporation: a compelling 'buy' amid strong financials
Wabash National Corporation has strong financial performance, with robust Q2 revenue and operating cash flow. The company's "One Wabash" structure and...
October 24, 2023, 1:00 am
Argenx to report third quarter 2023 financial results and business update on october 31, 2023
October 24, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of peop...
October 24, 2023, 1:00 am
Flowers foods: a healthy dividend, with shares near a strong entry point
This packaged bakery food company has a significant 17.4% share of the US bread market. It is wisely updating ...
October 24, 2023, 12:24 am
Clearfield: being greedy when others are fearful
Clearfield experienced a significant run-up in stock price fueled by strong growth and optimistic guidance, but has since seen a steep decline. Despit...
October 24, 2023, 12:15 am
Major dollar weakness limits the decline of gold pricing today
Dollar Weakness Mitigates Gold Price Decline Amidst Rising Middle East Tensions Gold prices, both physical and futures, are down about $8.00 to $9.00 ...
October 23, 2023, 11:10 pm